Inhibition of ACE with the centrally acting captopril retarded the development of hippocampal tau phosphorylation, signs of neurodegeneration, and amyloid beta (A4) precursor protein (App) upregulation in rats subjected to chronic unpredictable mild stress, as a model, which reproduces major pathological features of sporadic AD. Here, ACE is linked to Alzheimer disease.